Literature DB >> 3732310

Uptake of 131I-MIBG by medullary carcinoma of thyroid in familial cases.

G Coutris, J N Talbot, G Kabla, C Calmettes, G Milhaud.   

Abstract

Medullary carcinoma of the thyroid (MCT) and pheochromocytoma are APUD tumors. MIBG (Meta Iodo Benzyl Guanidine) uptake by pheochromocytomas is now well known but very few cases of MIBG uptake in sporadic MCT have been described. We report here the two first cases of inherited MCT with MIBG uptake.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3732310     DOI： 10.1007/bf00364733

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  10 in total

1.  Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity.

Authors:  J B HAZARD; W A HAWK; G CRILE
Journal:  J Clin Endocrinol Metab       Date:  1959-01       Impact factor: 5.958

2.  [Epithelioma of the thyroid secreting thyrocalcitonin].

Authors:  G Milhaud; M Tubiana; C Parmentier; G Coutris
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1968-02-05

3.  Scintigraphic imaging of carcinoid tumours with 131I-metaiodobenzylguanidine.

Authors:  M Fischer; D Kamanabroo; H Sonderkamp; T Proske
Journal:  Lancet       Date:  1984-07-21       Impact factor: 79.321

4.  Scintigraphic imaging of neuroblastoma with [131-I]iodobenzylguanidine.

Authors:  J Treuner; U Feine; D Niethammer; W Müller-Schaumburg; J Meinke; E Eibach; R Dopfer; T Klingebiel; S Grumbach
Journal:  Lancet       Date:  1984-02-11       Impact factor: 79.321

5.  Imaging of medullary thyroid cancer with 131I-MIBG.

Authors:  K Endo; K Shiomi; K Kasagi; J Konishi; K Torizuka; K Nakao; H Tanimura
Journal:  Lancet       Date:  1984-07-28       Impact factor: 79.321

6.  [Medullary cancer of the thyroid in type IIB multiple endocrine neoplasia. Uptake of meta-iodo-benzylguanidine labeled with iodine 131].

Authors:  P Chamouard; H Jouin; A Varra; J P Weill; A Constantinesco
Journal:  Presse Med       Date:  1985-06-22       Impact factor: 1.228

Review 7.  The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept.

Authors:  A G Pearse
Journal:  J Histochem Cytochem       Date:  1969-05       Impact factor: 2.479

8.  The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.

Authors:  M Nakajo; B Shapiro; J Copp; V Kalff; M D Gross; J C Sisson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1983-08       Impact factor: 10.057

9.  Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.

Authors:  T Sone; M Fukunaga; N Otsuka; R Morita; A Muranaka; S Yanagimoto; T Tomomitsu; H Nakayama; T Harada
Journal:  J Nucl Med       Date:  1985-06       Impact factor: 10.057

10.  Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine.

Authors:  T W Valk; M S Frager; M D Gross; J C Sisson; D M Wieland; D P Swanson; T J Mangner; W H Beierwaltes
Journal:  Ann Intern Med       Date:  1981-06       Impact factor: 25.391
  10 in total
  2 in total

1.  Utility of thallium-201 and iodine-123 metaiodobenzylguanidine in the scintigraphic detection of neuroendocrine neoplasia.

Authors:  F Montravers; G Coutris; L Sarda; B Mensch; J N Talbot
Journal:  Eur J Nucl Med       Date:  1993-11

2.  Thyroid uptake of MIBG in Sipple's syndrome.

Authors:  R Perdrisot; V Rohmer; J J Lejeune; J C Bigorgne; P Jallet
Journal:  Eur J Nucl Med       Date:  1988
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.